Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
2,062
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Construction and validation of nomograms for predicting the prognosis of grade 3 endometrial endometrioid adenocarcinoma cancers: a SEER-based study

Xiaofei Liua Department of Obstetrics and Gynecology, Shenyang Women’s and Children’s Hospital, Shenyang, ChinaView further author information
,
Junbo Zhaoa Department of Obstetrics and Gynecology, Shenyang Women’s and Children’s Hospital, Shenyang, ChinaView further author information
,
Zhiwei Suna Department of Obstetrics and Gynecology, Shenyang Women’s and Children’s Hospital, Shenyang, ChinaView further author information
&
Guangwei Wangb Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, ChinaCorrespondence[email protected]
View further author information
Pages 1752-1765 | Received 09 Feb 2021, Accepted 21 Apr 2021, Published online: 11 May 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
  • Tirosh I, Izar B, Prakadan SM, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189–196.
  • Cancer Genome Atlas Research N, Albert Einstein College of M, Analytical Biological S, et al. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–384.
  • Wang C, Yang C, Wang W, et al. A prognostic nomogram for cervical cancer after surgery from SEER database. J Cancer. 2018;9(21):3923–3928.
  • Wan G, Gao F, Chen J, et al. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma. BMC Cancer. 2017;17(1):91.
  • Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e80.
  • Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer. 2019;145(7):1719–1730.
  • Anderson C, Bae-Jump VL, Broaddus RR, et al. Long-term patterns of excess mortality among endometrial cancer survivors. Cancer Epidemiol Biomarkers Prev. 2021. DOI:10.1158/1055-9965.EPI-20-1631
  • Uccella S, Falcone F, Greggi S, et al. Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study. J Gynecol Oncol. 2018;29(6):e100.
  • Zhu L, Sun X, Bai W. Nomograms for predicting cancer-specific and overall survival among patients with endometrial carcinoma: a SEER based study. Front Oncol. 2020;10:269.
  • Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol. 2021;154:327–353.
  • Bosse T, Nout RA, McAlpine JN, et al. Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups. Am J Surg Pathol. 2018;42(5):561–568.
  • Bell DW, Ellenson LH. Molecular genetics of endometrial carcinoma. Annu Rev Pathol. 2019;14(1):339–367.
  • Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016 27;(1)16–41.
  • Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Radiother Oncol. 2015;117(3):559–581.
  • Chen JL, Huang YS, Huang CY, et al. Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study. Radiat Oncol. 2020;15(1):72.
  • Wu J, Zhang H, Li L, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301–312.
  • Bansal N, Herzog TJ, Seshan VE, et al. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior. Obstet Gynecol. 2008;112(1):64–70.
  • McGunigal M, Liu J, Kalir T, et al. Survival differences among uterine papillary serous, clear cell and grade 3 endometrioid adenocarcinoma endometrial cancers: a national cancer database analysis. Int J Gynecol Cancer. 2017;27(1):85–92.
  • Wakayama A, Kudaka W, Matsumoto H, et al. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer. Int J Clin Oncol. 2018;23(3):532–538.
  • Helpman L, Perri T, Lavee N, et al. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study. Int J Gynecol Cancer. 2019;29(1):133–139.
  • Chapman BV, Swanick CW, Ning MS, et al. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol. 2019;154(1):22–28.
  • Coll-de La Rubia E, Martinez-Garcia E, Dittmar G, et al. Prognostic biomarkers in endometrial cancer: a systematic review and meta-analysis. J Clin Med. 2020;9(6):1900.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.